Holen Sie sich die Stockscreener-App
0.5616
5.56%
0.0296
Schlusskurs vom Vortag:
$0.532
Offen:
$0.54
24-Stunden-Volumen:
852.64K
Relative Volume:
0.49
Marktkapitalisierung:
$21.75M
Einnahmen:
$3.04M
Nettoeinkommen (Verlust:
$-33.97M
KGV:
-0.4223
EPS:
-1.33
Netto-Cashflow:
$-52.47M
1W Leistung:
+33.71%
1M Leistung:
+1.74%
6M Leistung:
-59.89%
1J Leistung:
-80.83%
1-Tages-Spanne:
$0.54
$0.5886
1-Wochen-Bereich:
$0.416
$0.5886
52-Wochen-Spanne:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Firmenname
Rani Therapeutics Holdings Inc
Sektor
Branche
Telefon
(408) 457-3700
Adresse
2051 RINGWOOD AVENUE, SAN JOSE
Vergleichen Sie RANI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.5544 | 23.19M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.55 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.54 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.52 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.42 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.26 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-14 | Eingeleitet | Maxim Group | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-10-11 | Eingeleitet | UBS | Buy |
| 2022-07-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
When is Rani Therapeutics Holdings Inc. stock expected to show significant growthUnlock exclusive stock market insights - jammulinksnews.com
What makes Rani Therapeutics Holdings Inc. stock price move sharplyYearly Trend Summary and Opportunity Breakdown - Newser
Sector ETF performance correlation with Rani Therapeutics Holdings Inc.Free Breakout Momentum Picks With Protection - Newser
How volatile is Rani Therapeutics Holdings Inc. stock compared to the marketLightning-fast capital gains - jammulinksnews.com
How many analysts rate Rani Therapeutics Holdings Inc. as a “Buy”Capitalize on emerging market sectors - jammulinksnews.com
What is the dividend policy of Rani Therapeutics Holdings Inc. stockGet real-time alerts on top stocks - jammulinksnews.com
Is it the right time to buy Rani Therapeutics Holdings Inc. stockSuperior stock growth - jammulinksnews.com
Does Rani Therapeutics Holdings Inc. stock perform well during market downturnsAchieve explosive financial results today - jammulinksnews.com
How Rani Therapeutics Holdings Inc. stock performs during market volatilitySmart Trading With Safety Margin - Newser
Will Rani Therapeutics Holdings Inc. Stock Benefit from AI and Green Energy Trends3x Growth Potential - Newser
What analysts say about Rani Therapeutics Holdings Inc. stockExplosive returns - PrintWeekIndia
Is Rani Therapeutics Holdings Inc. a good long term investmentFree Wealth Planning Blueprint - Autocar Professional
Rani Therapeutics Holdings Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
What drives Rani Therapeutics Holdings Inc. stock priceHigh-yield capital appreciation - jammulinksnews.com
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Rani Therapeutics Announces New Securities Purchase Agreement - The Globe and Mail
Rani Therapeutics Shares Drop Sharply Following $3 Million Direct Offering Announcement - MSN
Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement - MSN
Rani Therapeutics stock plunges after $3 million registered direct offering By Investing.com - Investing.com India
Rani Therapeutics stock plunges after $3 million registered direct offering - Investing.com
Rani Therapeutics secures $3 million through registered direct offering By Investing.com - Investing.com South Africa
Rani Therapeutics secures $3 million through registered direct offering - Investing.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - The Manila Times
Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan
Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews
Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rani Therapeutics Holdings Inc-Aktie (RANI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
| South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
0.71%
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):